Efficacy and safety of transurethral resection of bladder tumour combined with chemotherapy and immunotherapy in bladder-sparing therapy in patients with T1 high-grade or T2 bladder cancer: a protocol for a randomized controlled trial

Abstract Background Bladder cancer is the tenth most common cancer worldwide. For patients with T1 high-grade or T2 bladder cancer, radical cystectomy is recommended. However, radical cystectomy is associated with various complications and has a detrimental impact on the quality of life. Bladder-spa...

Full description

Bibliographic Details
Published in:BMC Cancer
Main Authors: Xiangwei Yang, Shiqiang Zhang, Yajiao Cui, Yamei Li, Xinyue Song, Jun Pang
Format: Article
Language:English
Published: BMC 2023-04-01
Subjects:
Bladder cancer
Chemotherapy
Immunotherapy
Transurethral resection of bladder tumour
Bladder-sparing therapy
Efficacy
Online Access:https://doi.org/10.1186/s12885-023-10798-2

Internet

https://doi.org/10.1186/s12885-023-10798-2

Similar Items